Australian company Telix Pharmaceuticals (ASX:TLX) has announced the Ministry of Health of the Czech Republic has become the first European health authority to grant a national authorisation allowing the use of TLX591-CDx.
Czech Republic authorises Telix's prostate cancer imaging product
February 17, 2021 Australian Biotech
Latest Video
New Stories
-
BMS' Dr Greg Cook on enhancing regulatory and reimbursement processes
March 9, 2021 - - Latest News -
Daily updates on COVID-19 vaccine - 9 March 2021
March 9, 2021 - - COVID-19 -
PAIG companies mark International Women's Day 2021
March 9, 2021 - - Latest News -
Time for intervention on this 'unlawful exercise of power'
March 9, 2021 - - Latest News -
The three women leading emerging Australian biotech
March 8, 2021 - - Australian Biotech -
Bupa's Emily Amos on the need for 'bold' reform
March 8, 2021 - - Other Health -
Noxopharm launches second part of NOXCOVID-1 clinical trial
March 8, 2021 - - Australian Biotech